Scientific research
Intestinal microbiota could be a therapeutic target for preventing and managing tolerance to opioids.
Two enzymes produced by gut microbiota can convert the blood type A into 0. The findings may improve the capacity of blood banks.
The gut microbiota could determine how we respond to drugs. The findings, published in Nature, could lead to ways of making medications work better.
A study conducted at MIT, published in Cell Host & Microbe, investigated the role of adaptive mutations in the gut microbiome of healthy people.
Does the space environment affect the composition of the human microbiota? A large study published in Science sheds light on the question.
The microbiome may be a source for biomarkers leading to therapeutic discoveries and diagnostics. We discuss it with Emily Hollister, Vice President of Diversigen.
Richard Ellis, Head of Business Development at Biose, explains how CDMO companies assist start-ups in bringing live biotherapeutic products to the market.
Social contacts shape the composition of the human microbiota. That’s according to a study by Ilana Brito of Cornell University in Ithaca, New York, et al.
Alan G. Wade, the founder of CPS Research, talks about how they analyze the microbiota to assess the impact of probiotics on health.
The gut microbiota differs between ethnic groups, a study led by Andrew Brooks at Vanderbilt University in Nashville and published in PLOS Biology claims.
